New trial available: Click on any alert below and access our regulatory alerts and get timely notifications sent to your inbox for 7 days.
24th March 2023
24th March 2023
24th March 2023
9th March 2023
8th March 2023
US – South Dakota: House Bill 1209 is with the governor after being passed by the Senate. It would require containers holding in-process hemp during transport to have a label stating that it is in process and not intended for human consumption. It would also repeal a requirement for the state attorney general to present a report on how legalising hemp has affected enforcement of other controlled substances law, such as cannabis prosecutions.
8th March 2023
US – South Dakota: House Bill 1150 has been signed by the governor and enacted into law. It waives a medical cannabis patient’s fee for a second written certification after a follow-up assessment with their doctor. The fee can be waived once per calendar year.
7th March 2023
US – South Dakota: House Bill 1053, which would prohibit written certification to obtain medical cannabis “to a patient who is pregnant or breastfeeding”, has been passed by the Senate and now heads to the governor’s desk.
7th March 2023
US – South Dakota: Senate Bill 1 has been passed by the House in an amended version that must be reconciled with the Senate version before the bill heads to the governor’s desk. It would add eight specific qualifying conditions for medical cannabis: cancer, epilepsy, multiple sclerosis, amyotrophic lateral sclerosis (ALS), post-traumatic stress disorder (PTSD), Crohn’s disease, Aids, and HIV. In the House version, glaucoma was removed from the list. The bill would also remove the process for citizens to petition to add qualifying conditions and allow the Legislature to determine which ailments or disorders qualify for medical cannabis treatment.
2nd March 2023
US - South Dakota: House Bill 1150 has been passed by the Senate and now heads to the governor’s desk. HB 1150 would waive a medical cannabis patient’s fee for a second written certification after a follow-up assessment with their doctor. The fee can be waived once per calendar year.
28th February 2023
US - South Dakota: House Bill 1209 has been passed by the Senate and now heads to the governor’s desk. It would revise provisions on industrial hemp by requiring containers holding in-process hemp during transport to have a label stating that it is in process and not intended for human consumption, and by increasing the total delta-9 THC cap from 1% to 5% for hemp materials being processed by a licensee.
22nd February 2023
US - South Dakota: House Bill 1226, which has been passed by the House and now heads to the Senate, would require the Department of Health to establish labelling, marketing, packaging and testing requirements for products containing intoxicating hemp-derived cannabinoids, such as delta-8 and delta-10 THC.
Sign up to access our business and regulatory briefings and get the most updated news, insights and our expert analysis to keep you on top of worldwide industry trends.
By signing up you agree to our Terms and Conditions Please note trial access may take up to 24 hours to be granted as access must be qualified by a member of the CBD-Intel team.